The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Prevalence of Age-Related Macular Degeneration in Europe
Open accessAbstract
PURPOSE: Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly of European ancestry. Risk profiles and treatment options have changed considerably over the years, which may have affected disease prevalence and outcome. We determined the prevalence of early and late AMD in Europe from 1990 to 2013 using the European Eye Epidemiology (E3) consortium, and made projections for the future. DESIGN: Meta-analysis of prevalence data. PARTICIPANTS: A total of 42 080 individuals 40 years of age and older participating in 14 population-based cohorts from 10 countries in Europe. METHODS: AMD was diagnosed based on fundus photographs using the Rotterdam Classification. Prevalence of early and late AMD was calculated using random-effects meta-analysis stratified for age, birth cohort, gender, geographic region, and time period of the study. Best-corrected visual acuity (BCVA) was compared between late AMD subtypes; geographic atrophy (GA) and choroidal neovascularization (CNV). MAIN OUTCOME MEASURES: Prevalence of early and late AMD, BCVA, and number of AMD cases. RESULTS: Prevalence of early AMD increased from 3.5% (95% confidence interval [CI] 2.1%-5.0%) in those aged 55-59 years to 17.6% (95% CI 13.6%-21.5%) in those aged ≥85 years; for late AMD these figures were 0.1% (95% CI 0.04%-0.3%) and 9.8% (95% CI 6.3%-13.3%), respectively. We observed a decreasing prevalence of late AMD after 2006, which became most prominent after age 70. Prevalences were similar for gender across all age groups except for late AMD in the oldest age category, and a trend was found showing a higher prevalence of CNV in Northern Europe. After 2006, fewer eyes and fewer ≥80-year-old subjects with CNV were visually impaired (P = 0.016). Projections of AMD showed an almost doubling of affected persons despite a decreasing prevalence. By 2040, the number of individuals in Europe with early AMD will range between 14.9 and 21.5 million, and for late AMD between 3.9 and 4.8 million. CONCLUSION: We observed a decreasing prevalence of AMD and an improvement in visual acuity in CNV occuring over the past 2 decades in Europe. Healthier lifestyles and implementation of anti-vascular endothelial growth factor treatment are the most likely explanations. Nevertheless, the numbers of affected subjects will increase considerably in the next 2 decades. AMD continues to remain a significant public health problem among Europeans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wong, W. L., Su, X., Li, X., Cheung, C. M. G., Klein, R., Cheng, C.-Y., & Wong, T. Y. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70145-1 · Cited by 5,331
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
(2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102673 · Cited by 2,669
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
THE ESTIMATION AND SIGNIFICANCE OF THE LOGARITHM OF A RATIO OF FREQUENCIES
HALDANE, B. J. B. S. (1956) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01285.x · Cited by 1,076
Prevalence of age-related maculopathy in Australia
Mitchell, P., Smith, W., Attebo, K., & Wang, J. J. (1995) · Ophthalmology · doi:10.1016/s0161-6420(95)30846-9 · Cited by 1,062
Incidence of dementia over three decades in the Framingham heart study
Satizabal, C. L., Beiser, A. S., Chouraki, V., Chêne, G., Dufouil, C., & Seshadri, S. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1504327 · Cited by 1,051
Klaver, C. C. W. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.5.653 · Cited by 881
Self-citationAge-related macular degeneration
de Jong, P. T. V. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062326 · Cited by 787
Prevalence of Age-Related Macular Degeneration in the US Population
Klein, R. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2010.318 · Cited by 514
Cited by
Age-related macular degeneration
Mitchell, P., Liew, G., Gopinath, B., & Wong, T. Y. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31550-2 · Cited by 1,511
Wallace, T. C., Bailey, R. L., Blumberg, J. B., Burton-Freeman, B., Chen, C.-Y. O., Crowe-White, K. M., Drewnowski, A., Hooshmand, S., Johnson, E., Lewis, R., et al. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2019.1632258 · Cited by 638
Objectives, design and main findings until 2020 from the Rotterdam Study
Ikram, M. A., Brusselle, G., Ghanbari, M., Goedegebure, A., Ikram, M. K., Kavousi, M., Kieboom, B. C. T., Klaver, C. C. W., de Knegt, R. J., Luik, A. I., et al. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00640-5 · Cited by 452
Self-citationThe Role of Inflammation in Age-Related Macular Degeneration
Tan, W., Zou, J., Yoshida, S., Jiang, B., & Zhou, Y. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.49890 · Cited by 311
Monés, J., Singh, R. P., Bandello, F., Souied, E., Liu, X., & Gale, R. (2020) · Ophthalmologica · doi:10.1159/000502747 · Cited by 110
Self-citation
Metadata
- Authors
- Colijn, J. M., Buitendijk, G. H. S., Prokofyeva, E., Alves, D., Cachulo, M. L., Khawaja, A. P., Cougnard-Gregoire, A., Merle, B. M. J., Korb, C., Erke, M. G., Bron, A., Anastasopoulos, E., Meester-Smoor, M. A., Segato, T., Piermarocchi, S., de Jong, P. T. V. M., Vingerling, J. R., Topouzis, F., Creuzot-Garcher, C., Bertelsen, G., Pfeiffer, N., Fletcher, A. E., Foster, P. J., Silva, R., Korobelnik, J.-F., Delcourt, C., Klaver, C. C. W., Ajana, S., Arango-Gonzalez, B., Arndt, V., Bhatia, V., Bhattacharya, S. S., Biarnés, M., Borrell, A., Bühren, S., Calado, S. M., Colijn, J. M., Cougnard-Grégoire, A., Dammeier, S., de Jong, E. K., De la Cerda, B., Delcourt, C., den Hollander, A. I., Diaz-Corrales, F. J., Diether, S., Emri, E., Endermann, T., Ferraro, L. L., Garcia, M., Heesterbeek, T. J., Honisch, S., Hoyng, C. B., Kersten, E., Kilger, E., Klaver, C. C. W., Langen, H., Lengyel, I., Luthert, P., Maugeais, C., Meester-Smoor, M., Merle, B. M. J., Monés, J., Nogoceke, E., Peto, T., Pool, F. M., Rodríguez, E., Ueffing, M., Ulrich Bartz-Schmidt, K. U., van Leeuwen, E. M., Verzijden, T., Zumbansen, M., Acar, N., Anastosopoulos, E., Azuara-Blanco, A., Bergen, A., Bertelsen, G., Binquet, C., Bird, A., Brétillon, L., Bron, A., Buitendijk, G., Cachulo, M. L., Chakravarthy, U., Chan, M., Chang, P., Colijn, J., Cougnard-Grégoire, A., Creuzot-Garcher, C., Cumberland, P., Cunha-Vaz, J., Daien, V., Deak, G., Delcourt, C., Delyfer, M.-N., den Hollander, A., Dietzel, M., Erke, M. G., Fauser, S., Finger, R., Fletcher, A., Foster, P., Founti, P., Göbel, A., Gorgels, T., Grauslund, J., Grus, F., Hammond, C., Helmer, C., Hense, H.-W., Hermann, M., Hoehn, R., Hogg, R., Holz, F., Hoyng, C., Jansonius, N., Janssen, S., Khawaja, A., Klaver, C., Korobelnik, J.-F., Lamparter, J., Le Goff, M., Leal, S., Lechanteur, Y., Lehtimäki, T., Lotery, A., Leung, I., Mauschitz, M., Merle, B., Meyer zu Westrup, V., Midena, E., Miotto, S., Mirshahi, A., Mohan-Saïd, S., Mueller, M., Muldrew, A., Nunes, S., Oexle, K., Peto, T., Piermarocchi, S., Prokofyeva, E., Rahi, J., Raitakari, O., Ribeiro, L., Rougier, M.-B., Sahel, J., Salonikiou, A., Sanchez, C., Schmitz-Valckenberg, S., Schweitzer, C., Segato, T., Shehata, J., Silva, R., Silvestri, G., Simader, C., Souied, E., Springelkamp, H., Tapp, R., Topouzis, F., Verhoeven, V., Von Hanno, T., Vujosevic, S., Williams, K., Wolfram, C., Yip, J., Zerbib, J., & Zwiener, I.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 124
- Issue
- 12
- Pages
- 1753-1763
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2734721636
- Cited by
- 486
- References
- 50
- FWCI
- 35.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence of Age-Related Macular Degeneration in Europe. https://app.cochat.ai/papers/10.1016/j.ophtha.2017.05.035
- The paper
- Colijn, J. M., Buitendijk, G. H. S., Prokofyeva, E., Alves, D., Cachulo, M. L., Khawaja, A. P., Cougnard-Gregoire, A., Merle, B. M. J., Korb, C., Erke, M. G., Bron, A., Anastasopoulos, E., Meester-Smoor, M. A., Segato, T., Piermarocchi, S., de Jong, P. T. V. M., Vingerling, J. R., Topouzis, F., Creuzot-Garcher, C., . . . Zwiener, I. (2017). Prevalence of Age-Related Macular Degeneration in Europe. Ophthalmology. https://doi.org/10.1016/j.ophtha.2017.05.035
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.